Stock Market News1 month 5 Biotech Stocks Likely to Outperform as Industry Prospects Look BrightZacks
New drug approvals and strong pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position EXEL, BPMC, CRSP, FOLD and VRNA well in this volatile sector.
Biotech · Biotech Stocks · Current · Earnings
X